Market closedADR

Haleon/$HLN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Haleon

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Ticker

$HLN

Trading on

NYSE

Industry

Personal Care Products

Employees

25,408

Haleon Metrics

BasicAdvanced
$44B
Market cap
58.36
P/E ratio
$0.17
EPS
0.19
Beta
$0.16
Dividend rate
1.08%
Dividend yield
$44B
0.19
$10.67
$7.89
6.6M
$0.16
54.175
6.26%
58.362
6.26
2.09
-3.54
1.62%
1.08%
-0.65%
-2.93%

What the Analysts think about Haleon

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Haleon stock.

Haleon Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Haleon Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HLN

$

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Haleon stock?

Haleon (HLN) has a market cap of $44B as of December 13, 2024.

What is the P/E ratio for Haleon stock?

The price to earnings (P/E) ratio for Haleon (HLN) stock is 58.36 as of December 13, 2024.

Does Haleon stock pay dividends?

Yes, the Haleon (HLN) stock pays dividends to shareholders. As of December 13, 2024, the dividend rate is $0.15798 and the yield is 1.08%. Haleon has a payout ratio of 0% on a trailing twelve-month basis.

When is the next Haleon dividend payment date?

The next Haleon (HLN) dividend payment date is unconfirmed.

What is the beta indicator for Haleon?

Haleon (HLN) has a beta rating of 0.19. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.